Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01171625 · ClinicalTrials.gov registry record · NA
Carpentier-Edwards PERIMOUNT Magna Ease Pericardial Bioprosthesis, Model 3300TFX
A NA study, sponsored by Edwards Lifesciences.
- Completed
- Registry status
- NA
- Development phase
- 283
- Enrollment target
NCT01171625 is a NA study that has completed, run by Edwards Lifesciences. The registered enrollment target is 283 participants.
The verdict
NCT01171625, a NA study, has completed, sponsored by Edwards Lifesciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 283 participants
- Enrollment target
Study Summary
The purpose of the study is to demonstrate the long term safety and effectiveness of the Carpentier-Edwards PERIMOUNT Magna Ease Valves in patients undergoing aortic valve replacement with or without concomitant procedures requiring cardiopulmonary bypass.
Interventions
- DEVICE Implantation of CEP Magna Ease Model 3300TFX
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 283 participants |
| Start Date | 2007-10 |
| Est. Completion | 2018-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01171625
The ClinicalTrials.gov registry entry for NCT01171625 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 283 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Edwards Lifesciences, which has 57 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Implantation of CEP Magna Ease Model 3300TFX is the first listed.
NCT01171625 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01171625 about?
NCT01171625 is a clinical study titled "Carpentier-Edwards PERIMOUNT Magna Ease Pericardial Bioprosthesis, Model 3300TFX". The purpose of the study is to demonstrate the long term safety and effectiveness of the Carpentier-Edwards PERIMOUNT Magna Ease Valves in patients undergoing aortic valve replacement with or without concomitant procedures requiring cardiopulmonary bypass.
What is the current status of trial NCT01171625?
This trial is currently completed. It is a NA study. The enrollment target is 283 participants. The study started on 2007-10. Estimated completion is 2018-09.
What interventions are being tested in trial NCT01171625?
The interventions under investigation include: Implantation of CEP Magna Ease Model 3300TFX (DEVICE).
Who is sponsoring clinical trial NCT01171625?
This trial is sponsored by Edwards Lifesciences, which has 57 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.